Breast Lesion Localization Market – Growth, Trends, COVID-19 Impact and Forecasts (2022 to 2027)

Breast Lesion Localization Market was valued at US$ 244.32M. in 2021. The Global Breast Lesion Localization Market size is estimated to grow at a CAGR of 4.06 % over the forecast period.

Breast Lesion Localization Market Overview:

The report explores the Breast Lesion Localization market's segments (Techniques, End-User, Application, and Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). This market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2017 to 2020. The report investigates the Breast Lesion Localization market's drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Breast Lesion Localization Market's contemporary competitive scenario. Breast Lesion Localization Market To know about the Research Methodology:-Request Free Sample Report 2021 is considered as a base year to forecast the market from 2022 to 2027. 2021’s market size is estimated on real numbers and outputs of the key players and major players across the globe. The past five years' trends are considered while forecasting the market through 2027. 2020 is a year of exception and analysis, especially with the impact of lockdown by region.

Breast Lesion Localization Market Dynamics:

Increase in the demand for the Breast Lesion Localization Devices for early detection of Breast Cancer: Breast Cancer is one of the most common diseases that is affecting women in developed as well as developing countries. The changes in the lifestyle, which includes the behavioral factors, dietary preference, and physical activities usually worsen the Breast Cancer. Women with greater insulin levels overnight in their blood can cause Malignancies in Breast Cancer. Drinking Alcohol, obesity, use of birth control pills, menopausal hormone treatment, and Breast implants are the factors which are leads to Breast Cancer. According to the statistics given by the American Cancer Society in 2020; Alcohol intake probably increases the risk of Breast Cancer. The data included, that women who have one alcoholic drink per day can have a risk of 7-10% of suffering from Breast Cancer. The advanced localization approach can make breast cancer surgeries more accurate, simple, and precise. The growing pervasiveness of Breast Cancer is growing the demand for Breast Lesion Localization Devices. Breast Cancer can spread to other areas of the body. The most common detectable site of Breast Cancer is the lymph nodes which cannot be felt by touching. The Survival rate of people suffering from Breast Cancer for at least 5 years is 40% in South Africa, 67% in India, and 92% in high-income countries like North America and Europe. The early detection and the treatment are proven to be successful in the high-income countries as it has good Breast Lesion Localization devices which decrease the risk associated with Breast Cancer. The Government is organizing the Breast Cancer awareness programs: There is an increase in the demand for the Breast Lesion Localization Devices that are used in the detection and mapping of Breast Cancer. There are only a few players involved in the of the manufacturers are involved in the manufacturing of the Breast Lesion Localization Devices to date. There is a significant growth opportunity for various other small and large manufacturers for entering the Breast Lesion Localization Devices market. Breast Cancer is the most common disease that is affecting women in developed as well as developing countries. The early detection and mapping of Breast cancer can help the patent to cure effectively over certain medications. So, the early detection of breast cancer is very important for its treatment. Also, the government is organizing breast cancer awareness programs for raising the awareness of Breast Cancer among the population and eliminating the stigma associated with breast cancer symptoms and treatment. Hence, these factors are creating opportunities for the growth of the Breast Lesion Localization Devices Market during the forecast period. High cost associated with the Breast Lesion Localization Devices and the Breast Cancer treatment: There is a high cost associated with the Breast Lesion Localization Devices and there is a lack of trained professionals who can carry out critical and advanced operations for the detection of Breast Lesions Devices. The breast cancer surgeries like breast lumpectomy, breast biopsy, and some other procedures are there which require high-cost operations. Due to this high cost associated with the device, it leads to inaccessibility for many of the patients in the country which is one of the most important restraining factors of the market. The Breast Lesion Localization Device is the most advanced technology which is used in the detection of breast cancer in the early stages. For operating these devices, it requires expert staff trainees. Many hospitals in developing and underdeveloped countries lack skilled professionals for using the Breast Lesion Localization Devices for diagnosis and surgeries. These factors are expected to hamper the growth of the Breast Lesion Localization Devices Market during the forecast period. Breast Lesion Localization Market Trends: Breast Cancer is one of the most common diseases that is affecting women in developed as well as developing countries. The changes in the lifestyle, which includes the behavioral factors, dietary preference, and physical activities usually worsen the Breast Cancer. Alcohol intake probably increases the risk of Breast Cancer. The data included, that women who have one alcoholic drink per day can have a risk of 7-10% of suffering from Breast Cancer. The most common detectable site of Breast Cancer is the lymph nodes which cannot be felt by touching. There are only a few players involved in the of the manufacturers are involved in the manufacturing of the Breast Lesion Localization Devices to date.

Breast Lesion Localization Market Segment Analysis:

Based on Type, the wire localization segment dominates the market by holding the maximum market share of 32% in 2021. Wire localization is cost-effective and easy to use for surgeons and radiologists. While processing, also wire localization services have many options which can easily connect to radiology imaging devices with a guided wire. All these wires are leading to the growth of the wire localization segment. Hence, the wire localization segment dominates the Breast Lesion Localization Market. Also, the government is organizing breast cancer awareness programs for raising the awareness of breast cancer among the population. Hence all these factors are fuelling the growth of the Breast Lesion Localization device market during the forecast period. Based on the Usage, The Breast Biopsy segment is expected to hold the maximum market share and is estimated to grow at a CAGR of 5% during the forecast period. This segment accounted for 62% of overall shares in Breast Lesion Localization Devices Market in 2021. This is due to the increasing awareness of the early diagnosis of the Breast Lesion with Biopsy. This factor makes the breast biopsy segment grow with the great market space. Breast Lesion Localization Market

Breast Lesion Localization Market Regional Insights:

The North American region held the largest market share accounting for 35% in 2021. It is owing to the region’s reimbursement policies availability, and the availability of the government’s organized Cancer screening programs. The North American region constitutes the maximum number of the population suffering from Breast Cancer and also the government is making huge investments in the Breast Lesion Localization Devices and the medical requirements. These factors are contributing to the growth of the Breast Lesion Localization Market in North American countries. Hence the North American region held the largest market share during the forecast period. The European region is expected to witness significant growth at a CAGR of 9% through the forecast period. The increase in the incidence of breast cancer and the adoption of the advanced localization techniques for the treatment of Breast Cancer, lead to an increased rate of Breast cancer patients in the countries of the European Countries. These factors are leading to the growth of the Breast Lesion Localisation Market. Hence the European region is expected to witness significant growth during the forecast period. The objective of the report is to present a comprehensive analysis of the global Breast Lesion Localization Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the Breast Lesion Localization Market dynamic, and structure by analyzing the market segments and projecting the Breast Lesion Localization Market size. Clear representation of competitive analysis of key players by Design, price, financial position, product portfolio, growth strategies, and regional presence in the Breast Lesion Localization Market make the report investor’s guide.

Breast Lesion Localization Market Scope: Inquire before buying

Global Breast Lesion Localization Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2027
Historical Data: 2017 to 2021 Market Size in 2021: US $ 244.32Mn.
Forecast Period 2022 to 2027 CAGR: 4.06% Market Size in 2027: US $ 1818.9 Mn.
Segments Covered: by Type • Wire Localization • Radioisotope Localization o Radioguided Occult Lesion Localization o Radioactive Seed Localization • Magnetic Localization • Electromagnetic Localization • Other Localization Methods
by Usage • Breast Biopsy • Breast Conservation (Lumpectomy)

Breast Lesion Localization Market by Region

• North America • Europe • Asia Pacific • The Middle East and Africa • South America

Breast Lesion Localization Market Key Players:

• Hologic, Inc. (US) • Becton • Dickinson and Company (US) • Merit Medical Systems (US) • Leica Biosystems Nussloch GmbH (US) • Argon Medical Devices (US) • Laurane Medical LLC (France) • Endomagnetics Ltd. (UK) • Intramedical Imaging, LLC (US) • Isoaid (US) • Surgiceye GmbH (Germany) • Ranfac Corp. (US) • Mermaid Medical Group (Denmark) • Izi Medical Products, LLC (US) • Matek Medikal (Turkey) • Tsunami Medical Srl (Italy) • BPB Medica (Italy) • Sirius Medical Systems B.V. (Netherlands) • Molli Surgical Inc. (Canada) • Sterylab S.R.L. (Italy) • CP Medical (Georgia) • MDL SRL (Italy) • Biomedical Srl (Italy) • Elucent Medical (US) • Vigeo srl (Italy) • Medax Medical Devices (Italy). Frequently Asked Questions: 1) What segments are covered in the Breast Lesion Localization Market report? Ans. The segments covered in the Breast Lesion Localization Market report are based on Techniques, Power, User, and End-User 2) Which region holds the highest share in the Breast Lesion Localization Market? Ans. The North American region is expected to hold the highest share in the Breast Lesion Localization Market. 3) What is the market size of the Breast Lesion Localization Market by 2027? Ans. The market size of the Breast Lesion Localization Market by 2027 is US$ 310.15 Mn. 4) What is the forecast period for the Breast Lesion Localization Market? Ans. The Forecast period for the Breast Lesion Localization Market is 2022-2027. 5) What was the market size of the Breast Lesion Localization Market in 2021? Ans. The market size of the Breast Lesion Localization Market in 2021 was US$ 244.32M.
1. Global Breast Lesion Localization Market Size: Research Methodology 2. Global Breast Lesion Localization Market Size: Executive Summary 2.1. Market Overview and Definitions 2.1.1. Introduction to Global Breast Lesion Localization Market Size 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Breast Lesion Localization Market Size: Competitive Analysis 3.1. MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2. Consolidation in the Market 3.2.1 M&A by region 3.3. Key Developments by Companies 3.4. Market Drivers 3.5. Market Restraints 3.6. Market Opportunities 3.7. Market Challenges 3.8. Market Dynamics 3.9. PORTERS Five Forces Analysis 3.10. PESTLE 3.11. Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • South America 3.12. COVID-19 Impact 4. Global Breast Lesion Localization Market Size Segmentation 4.1. Global Breast Lesion Localization Market Size, by Type (2021-2027) • Wire Localization • Radioisotope Localization • Radioguided Occult Lesion Localization • Radioactive Seed Localization • Magnetic Localization • Electromagnetic Localization • Other Localization Methods 4.2. Global Breast Lesion Localization Market Size, by Usage (2021-2027) • Breast Biopsy • Breast Conservation (Lumpectomy) 5. North America Breast Lesion Localization Market (2021-2027) 5.1. North America Breast Lesion Localization Market Size, by Type (2021-2027) • Wire Localization • Radioisotope Localization • Radioguided Occult Lesion Localization • Radioactive Seed Localization • Magnetic Localization • Electromagnetic Localization • Other Localization Methods 5.2. North America Breast Lesion Localization Market Size by Usage (2021-2027) • Breast Biopsy • Breast Conservation (Lumpectomy) 5.3. North America Breast Lesion Localization Market, by Country (2021-2027) • United States • Canada • Mexico 6. European Breast Lesion Localization Market (2021-2027) 6.1. European Breast Lesion Localization Market, by Type (2021-2027) 6.2. European Breast Lesion Localization Market, by Usage (2021-2027) 6.3. European Breast Lesion Localization Market, by Country (2021-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Breast Lesion Localization Market (2021-2027) 7.1. Asia Pacific Breast Lesion Localization Market, by Type (2021-2027) 7.2. Asia Pacific Breast Lesion Localization Market, by Usage (2021-2027) 7.3. Asia Pacific Breast Lesion Localization Market, by Country (2021-2027) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. The Middle East and Africa Breast Lesion Localization Market (2021-2027) 8.1. The Middle East and Africa Breast Lesion Localization Market, by Type (2021-202The 7) 8.2. The Middle East and Africa Breast Lesion Localization Market, by Usage (2021-202The 7) 8.3. The Middle East and Africa Breast Lesion Localization Market, by Country (2021-2027) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Breast Lesion Localization Market (2021-2027) 9.1. South America Breast Lesion Localization Market, by Type (2021-2027) 9.2. South America Breast Lesion Localization Market, by Usage (2021-2027) 9.3. South America Breast Lesion Localization Market, by Country (2021-2027) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1. Hologic, Inc. (US) 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Becton 10.3. Dickinson and Company (US) 10.4. Merit Medical Systems (US) 10.5. Leica Biosystems Nussloch GmbH (US) 10.6. Argon Medical Devices (US) 10.7. Laurane Medical LLC (France) 10.8. Endomagnetics Ltd. (UK) 10.9. Intramedical Imaging, LLC (US) 10.10. Isoaid (US) 10.11. Surgiceye GmbH (Germany) 10.12. Ranfac Corp. (US) 10.13. Mermaid Medical Group (Denmark) 10.14. Izi Medical Products, LLC (US) 10.15. Matek Medikal (Turkey) 10.16. Tsunami Medical Srl (Italy) 10.17. BPB Medica (Italy) 10.18. Sirius Medical Systems B.V. (Netherlands) 10.19. Molli Surgical Inc. (Canada) 10.20. Sterylab S.R.L. (Italy) 10.21. CP Medical (Georgia) 10.22. MDL SRL (Italy) 10.23. Biomedical Srl (Italy) 10.24. Elucent Medical (US) 10.25. Vigeo srl (Italy) 10.26. Medax Medical Devices (Italy)

About This Report

Report ID 146706
Category Healthcare
Published Date May 2022
Updated Date
Contact Us